Suzanne Kafaja

Clinical trials

• Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background

  Principal investigator · Withdrawn

  University of California, Los Angeles

  2014–2018
• A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

  Site PI · Recruiting · Phase 3

  GlaxoSmithKline

  2024–2030
• A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

  Site PI · Recruiting · Phase 2

  Novartis Pharmaceuticals

  2024–2034
• A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  Site PI · Recruiting · Phase 2, Phase 3

  GlaxoSmithKline

  2023–2029